Revenio Group Oyj (CHIX:REG1VH) WACC %:3.52% (As of Jul. 03, 2026) — 53% Below Median


CHIX:REG1VH Revenio Group Oyj CHIX:REG1VH
77 GF Score
Price €16.47
GF Value €40.41
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj WACC %?

Revenio Group Oyj CHIX:REG1VH 77 WACC % is 3.52% as of Jul. 03, 2026, which is 53% below its 10-year median of 7.43. GuruFocus rates CHIX:REG1VH with a GF Score™ of 77/100 and a GF Value™ of €40.41. The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Revenio Group Oyj ranks better than 76.1% on this metric.

As of today (2026-07-03), Revenio Group Oyj's weighted average cost of capital is 3.52%%. Revenio Group Oyj's ROIC % is 14.70% (calculated using TTM income statement data). Revenio Group Oyj generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

For a comprehensive WACC calculation, please access the WACC Calculator.


Revenio Group Oyj  (CHIX:REG1Vh) WACC % Explanation

Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Revenio Group Oyj's weighted average cost of capital is 3.52%%. Revenio Group Oyj's ROIC % is 14.70% (calculated using TTM income statement data). Revenio Group Oyj generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.

2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.

3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.

4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.


Related Terms

Revenio Group Oyj WACC % Historical Data

* Premium members only.

The historical data trend for Revenio Group Oyj's WACC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revenio Group Oyj WACC % Chart

Revenio Group Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
WACC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.01 10.67 10.77 11.43 9.60

Revenio Group Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
WACC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.53 10.94 8.96 9.60 8.69

CHIX:REG1VH vs ABT, SYK, MDT: WACC % Comparison

For the Medical Devices subindustry, Revenio Group Oyj's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj WACC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's WACC % distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's WACC % falls into.


CHIX:REG1VH
77GF Score
Revenio Group Oyj CHIX:REG1VH
WACC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revenio Group Oyj WACC % Calculation

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.

WACC=E/(E + D)*Cost of Equity+D/(E + D)*Cost of Debt*(1 - Tax Rate)

1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Revenio Group Oyj's market capitalization (E) is €358.402 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Mar. 2026, Revenio Group Oyj's latest one-year quarterly average Book Value of Debt (D) is €5.4976 Mil.
a) weight of equity = E / (E + D) = 358.402 / (358.402 + 5.4976) = 0.9849
b) weight of debt = D / (E + D) = 5.4976 / (358.402 + 5.4976) = 0.0151

2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 3.3991%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Revenio Group Oyj's beta is -0.0309.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 3.3991% + -0.0309 * 6% = 3.2137%

3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
As of Mar. 2026, Revenio Group Oyj's interest expense (positive number) was €1.7 Mil. Its total Book Value of Debt (D) is €5.4976 Mil.
Cost of Debt = 1.7 / 5.4976 = 30.9226%.

4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = 4.8 / 20.5 = 23.41%.

Revenio Group Oyj's Weighted Average Cost Of Capital (WACC) for Today is calculated as:

WACC=E / (E + D)*Cost of Equity+D / (E + D)*Cost of Debt*(1 - Tax Rate)
=0.9849*3.2137%+0.0151*30.9226%*(1 - 23.41%)
=3.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about WACC % →
What does a WACC % of 3.52% mean?
Revenio Group Oyj (CHIX:REG1VH) has a WACC % of 3.52% as of Jul. 03, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Revenio Group Oyj and its competitors. This is 53% below median its historical median of 7.43. Over the past decade, Revenio Group Oyj's WACC % has ranged from 5.44 to 11.43. According to the industry distribution chart, Revenio Group Oyj ranks #207 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 23.9%.
Is Revenio Group Oyj's WACC % too high?
Revenio Group Oyj's current WACC % of 3.52% is 53% below median its 10-year median of 7.43. Over the past 10 years, this metric has ranged from a low of 5.44 to a high of 11.43. The Medical Devices & Instruments industry median WACC % is 9.22. Revenio Group Oyj's value of 3.52% is 61.8% below this industry median. Based on the distribution chart, Revenio Group Oyj ranks #207 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Revenio Group Oyj has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's WACC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #207 out of 866 companies for WACC %. This places Revenio Group Oyj in the top 24% of its industry — outperforming the majority of peers. The industry median WACC % is 9.22. Revenio Group Oyj's value of 3.52% is 61.8% below this benchmark. Historically, Revenio Group Oyj's own WACC % has ranged from 5.44 to 11.43 over the past decade. While the company's 10-year median is 7.43 vs. the industry median of 9.22, Revenio Group Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Medical Devices & Instruments company?
The median WACC % among Medical Devices & Instruments companies is 9.22, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revenio Group Oyj's current WACC % of 3.52% is 61.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median WACC % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current WACC % is 3.52%, which is 53% below median its own 10-year median of 7.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Revenio Group Oyj (CHIX:REG1VH) has a current WACC % of 3.52%. The stock's GF Value™ is €40.41, compared to a current price of €16.47 — trading 59.2% below its estimated fair value. The current WACC % is 3.52%, which is 53% below median its 10-year median of 7.43 and 61.8% below the Medical Devices & Instruments industry median of 9.22. Revenio Group Oyj's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Revenio Group Oyj (CHIX:REG1VH), the current WACC % is 3.52% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revenio Group Oyj (CHIX:REG1VH) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of €16.47 is trading 59.2% below its estimated GF Value™ of €40.41.

Key valuation signals for CHIX:REG1VH:

  • WACC %: 3.52% (53% below median its 10-year median of 7.43)
  • GF Value™: €40.41 vs. price of €16.47 (59.2% below fair value)
  • GF Score™: 77/100 with 2 warning signs
  • Industry Position: 61.8% below the Medical Devices & Instruments median (#207 of 866)

No single metric tells the full story. See the CHIX:REG1VH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
77GF Score

Get the complete analysis for CHIX:REG1VH

WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.47
Price
€40.41
GF Value